Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- fosamprenavir
- Lyfgenia (lovotibeglogene autotemcel)
Interactions between your drugs
fosamprenavir lovotibeglogene autotemcel
Applies to: fosamprenavir, Lyfgenia (lovotibeglogene autotemcel)
Fosamprenavir may interfere with the process used to make lovotibeglogene autotemcel from your own blood cells. The makers of lovotibeglogene autotemcel recommend that fosamprenavir be stopped before your blood stem cells are collected. You should speak with your doctor to ensure that fosamprenavir is stopped at the appropriate time. Lovotibeglogene autotemcel may also interfere with the results of certain types of laboratory tests. Be sure to speak with the laboratory or your healthcare provider if you need to be screened for certain types of viruses, like human immunodeficiency virus (HIV), to ensure that treatment with lovotibeglogene autotemcel does not interfere with the test. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
fosamprenavir food
Applies to: fosamprenavir
Fosamprenavir suspension should be administered on an empty stomach in adults, but with food in pediatric patients to help the taste and compliance. If vomiting occurs within 30 minutes after dosing the suspension, the dose should be repeated. Fosamprenavir tablets may be taken with or without food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.